LPCAT3 and metabolic dysfunction-associated steatotic liver disease: We compared the concentrations of the Complement C3f (1466.929±78.306 pg/ml) and Fibrinopeptide A (4.189±0.326 ng/ml) in NAFLD group with in control group (C3f 1159.357±99.624 pg/ml; FPA 3.039±0.483 ng/ml) by independent-samples T test, respectively.